KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Sang-We Kim

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 8건 중 1-8 번을 표시중입니다.

1 Article A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors Byoung Chul Cho ; Ji-Youn Han ; Sang-We Kim ; et al 2022
2 Article Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer Pasi A Jänne ; Christina Baik ; Wu-Chou Su ; et al 2022
3 Article First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial Sang-We Kim ; Adam Pluzanski ; Alain Vergnenegre ; et al 2022
4 Article Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial Margarita Majem ; Jonathan W Goldman ; Thomas John ; et al 2022
5 Article Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment Myeong Geun Choi ; Chang-Min Choi ; Dae Ho Lee ; et al 2022
6 Article Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung Cancer Shinkyo Yoon ; Hannah Yang ; Hyun-Min Ryu ; et al 2022
7 Article Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC Sang-We Kim ; Kye Young Lee ; Ajlan Atasoy ; et al 2022
8 Article The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study Jwa Hoon Kim ; Seyoung Seo ; Jee Hyun Kim ; et al 2022

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.